Gene Therapy Repairs Ravaged Immune System
Researches from the
University of California in Los Angeles, and the National
Human Genome Research Institute (NHGRI) of the National Institute
of Health, found the correlations of Gene therapy and immune system
dysfunction. According to Dr. Donald and Dr. Fabio, Gene therapy can safely
restore immune function in children with severe combined immunodeficiency
(SCID). Children with SCID are not able
to produce healthy and adequate lymphocytes compared to normal kids, thus they
are more susceptible to infections. Researchers found that one type of SCID
arise from a faulty gene that translates into enzyme adenosine deaminase (ADA).
Without this enzyme, toxic compounds build up in the body and in response lymphocyte’s
production is inhibited.
There were researches
about treating this condition with gene therapy by replacing damaged ADA gene
in the blood-forming stem cells found in bone marrow. However, they have had
trouble developing methods that effectively raises ADA level and leads to lasting
improvements in immune function.
In this case, Dr.
Donald and Dr. Fabio treated ten SCID patients with ADA deficiency by isolating
blood-forming stem cells from their bone marrow, manipulated the cells ’genes
correctly and treated with retroviral vectors, which delivered healthy ADA
genes. Later on, the corrected cells were infused back into the patient’s blood
stream. Four patients were remained with the same therapy mentioned before. The
other 6 additional patients, the doctors modified the treatment. They stopped
the enzyme-therapy before the procedure and patients received low-dose of
chemotherapy. Doctors state that this step proved to be important because it
allows them to find the optimal level for enhancing the efficacy of the
corrected stem cells by adjusting the chemotherapy dosage. Out of the 6
patients mentioned before, 3 of them received the refined procedure and have
had improved health for up to 5 years and have not needed enzyme replacement
injections. The other 3 patients did not have lasting improvements from the
procedure. This suggests the scientists to improve the therapy.
I found this article
interesting because based on what I read about this disease, children with this
condition have to take several painful weekly injections. This research enables
the possibility to find a less painful treatment with better results.
0 Comments:
Post a Comment
<< Home